I Amiri - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

I Amiri

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

EMBO Molecular Medicine|November 28, 2012

Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescenceYan Liu, Oriana E Hawkins, Yingjun Su, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012

RAF265 inhibits the growth of advanced human melanoma tumorsYingjun Su, Anna E Vilgelm, Mark C Kelley, et al.

Cancer Research Communications|October 30, 2025

Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid TumorsKristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

EMBO Molecular Medicine|November 28, 2012

Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescenceYan Liu, Oriana E Hawkins, Yingjun Su, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012

RAF265 inhibits the growth of advanced human melanoma tumorsYingjun Su, Anna E Vilgelm, Mark C Kelley, et al.

Cancer Research Communications|October 30, 2025

Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid TumorsKristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, et al.

Pageof 3